Please use this identifier to cite or link to this item:
|Title:||High levels of Granzyme B expression in invasive cervical carcinoma correlates to poor response to treatment|
|Authors:||Guzman, Valeska B. [UNIFESP]|
Silva, Ismael Dale Cotrim Guerreiro da [UNIFESP]
Brenna, Sylvia M. F.
Carvalho, Carmen R. N. [UNIFESP]
Ribalta, Julisa Chamorro Lascalas [UNIFESP]
Gerbase-Lima, Maria [UNIFESP]
Universidade Federal de São Paulo (UNIFESP)
Leonor Mendes Barros Hosp
|Publisher:||Taylor & Francis Inc|
|Citation:||Cancer Investigation. Philadelphia: Taylor & Francis Inc, v. 26, n. 5, p. 499-503, 2008.|
|Abstract:||The present study assessed, in cervical carcinoma, expression levels of seven immune response genes and sought correlation to response to treatment. the expression levels of C,026, CTLA4, ICOS, ICOSL, CD80 and CD86 and granzyme B genes were assessed by real-time RTPCR in pre-treatment tumor fragments. During the six-month follow-up after treatment, 8 patients presented tumor and 10 survived free of tumor. the only gene whose expression levels, were higher in patients with poor outcome (p = 0.03) was granzyme B. Further evaluation, in adequately powered prospective studies is warranted to confirm the data and to translate this observation to the clinical setting.|
|Appears in Collections:||Em verificação - Geral|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.